Dawaa Reference

infectious

Dysuria (painful or burning urination)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources5 sources

IDSA/ESCMID Cystitis 2011 · No dose - assessment step, no medicine given · Phenazopyridine Hydrochloride 100 mg tablets, FDA label sections Indications and Usage and Dosage and Administration (DailyMed set id 860f30ef-cfe3-4c35-8baf-dd788f02ac94) · Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph) · Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph)

Verified against5 documents
  • IDSA/ESCMID Cystitis 2011
  • Phenazopyridine Hydrochloride 100 mg tablets, FDA label sections Indications and Usage and Dosage and Administration (DailyMed set id 860f30ef-cfe3-4c35-8baf-dd788f02ac94)
  • No dose - assessment step, no medicine given
  • Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph)
  • Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (5)

  • Pain at the start of urination points to a urethral cause such as urethritis, while pain at the end suggests the bladder or prostate [burning pain]
  • Dysuria may come with fever, chills, flank or low back pain, nausea, vomiting, joint pain, blood in the urine, or urinary urgency and frequency [back pain · blood in the urine · burning on passing urine · chills · fever · joint pain · nausea · urinary urgency · vomiting]
  • Dysuria with no other symptoms most often points to chlamydia [burning on passing urine]
  • Genital ulcers accompanying dysuria suggest herpes simplex virus [burning on passing urine · genital ulcers]
  • New confusion is often the presenting symptom of a urinary tract infection in an older adult [confusion]

Signs — what you find (4)

  • A purulent urethral discharge points toward gonorrhea [pus · urethral discharge]
  • Exam may show fever, rash, suprapubic bladder tenderness, or joint pain [abdominal pain · fever · joint pain · lower abdominal pain · rash]
  • Fever with a rapid pulse or low blood pressure alongside dysuria suggests systemic infection [burning on passing urine · fever · hypotension · tachycardia]
  • Flank pain, blood in the urine, reduced output, and bladder spasms suggest obstruction from a stone or tumor [abdominal pain · blood in the urine · loin pain · spasm]

Tests (8)

  • Positive nitrites on urinalysis predict a positive urine culture 75% to 95% of the time
  • Positive leukocyte esterase, more than trace, predicts a positive culture 65% to 85% of the time
  • Gram-negative diplococci on Gram stain is diagnostic for gonorrhea
  • 5 or more white blood cells per oil-immersion field on urethral secretions is diagnostic for urethritis
  • A urine NAAT is the single most sensitive assay for gonorrhea or chlamydia in men
  • Ultrasound or CT is reserved for complicated dysuria with obstruction, unexplained fever, or suspected stones or tumors
  • Imaging is unnecessary in most straightforward cases of dysuria
  • Urine cytology and cystoscopy are used when hematuria or a smoking history over 10 pack-years raises concern for bladder cancer

If not this — what else fits (12)

  • Urethral pain syndrome causes dysuria, urinary frequency, and suprapubic discomfort with a negative urine culture
  • Reactive arthritis presents as the triad of urethritis, conjunctivitis, and arthritis
  • Infectious causes of dysuria include cystitis, urethritis, pyelonephritis, and other sexually transmitted infections
  • In women, vulvovaginitis or cervicitis can cause dysuria; in men, prostatitis or epididymo-orchitis can
  • Dermatologic causes include contact dermatitis, psoriasis, Behcet syndrome, lichen sclerosis and planus, and Stevens-Johnson syndrome
  • Endocrine causes include atrophic vaginitis and endometriosis
  • Anatomic causes include benign prostatic hypertrophy and urethral stricture
  • Neoplastic causes span renal cell, bladder, prostate, penile, vaginal, and vulvar cancer, lymphoma, and metastatic disease
  • Idiopathic causes include interstitial cystitis and urethral pain syndrome
  • Drug causes of dysuria include cyclophosphamide and ketamine
  • Traumatic causes include a foreign body, surgery, urinary tract instrumentation, or pelvic radiation
  • Noninfectious inflammatory causes include a stone, a urethral or ureteral stent, or pudendal neuralgia

SourceStatPearls "Dysuria" - disease-level clinical article

Presentation findings are traced to the source above.

Rx: Main treatment | Gonococcal urethritis - injectable

MAIN TREATMENT - choose one, plus any add-on marked below

1

NO DRUG THERAPY IN PRIMARY CARE (ASSESS FIRST)

1st line
Adult dose and duration

Dysuria is a symptom, not a diagnosis. In a non-pregnant woman with frequency and urgency and no vaginal discharge, cystitis is likely enough to treat on the history. Otherwise think again: vaginal discharge points to vaginitis or a sexually transmitted infection, flank pain and fever to pyelonephritis, and in a man dysuria is urethritis or prostatitis until proved otherwise. Ask about pregnancy every time. - Assess, then decide

Paediatric dose

Dysuria in an infant under 3 months, or with fever at any age, needs urgent assessment. Send the urine for culture before starting antibiotics, not after, and remember that urinary infection in a young child warrants thought about reflux.

Dose source

No dose - assessment step, no medicine given

Why

Treating every dysuria as cystitis is how chlamydia is missed in young women and how pyelonephritis gets sent home with a short course of tablets.

Cautions
  • Pregnancy changes the whole approach: asymptomatic bacteriuria is treated, a culture is always sent, and nitrofurantoin is avoided at term.
  • Fever, rigors, flank pain or vomiting is pyelonephritis, not cystitis. That needs a culture and a different, longer antibiotic course.
  • In a man, and in recurrent infection in a woman, send a urine culture rather than treating blind.
  • Dysuria with a new sexual partner, urethral or vaginal discharge, or pelvic pain: test for chlamydia and gonorrhoea, and treat the partner.
  • Visible blood in the urine that persists after the infection has been treated needs investigating for bladder cancer, particularly in a smoker over 45.
  • Sterile pyuria - white cells with no growth - should raise chlamydia, and in Egypt also urinary tuberculosis and schistosomiasis.
  • RED FLAG - Hematuria accompanying dysuria can signal urological obstruction from a stone or tumor and warrants further evaluation rather than empiric antibiotic treatment alone.
2

NITROFURANTOIN

1st line

Strength100 mg

Formoral.solid

Adult dose and duration

100 mg BID (monohydrate/macrocrystals) or 50 mg QID x 5 days

Paediatric dose

Specialist use only in children; 5-7 mg/kg/day divided QID

Dose source

IDSA/ESCMID Cystitis 2011

Why

When the picture is uncomplicated cystitis, this is the first-line antibiotic: it concentrates in the urine, resistance remains low, and it does little to gut flora.

Cautions
  • Contraindicated if eGFR < 45 mL/min.
  • Take with food to improve absorption and lessen GI upset.
  • It reaches therapeutic levels only in the bladder urine. It does not treat pyelonephritis or prostatitis.
  • Avoid at term in pregnancy and in the neonate - haemolysis risk in G6PD deficiency.
  • Pulmonary toxicity can occur on prolonged use, and urine turns brown.
Egyptian brands
Egyptian brandManufacturerIndicative price
COLIFURAN 100 MG 20 TABS.KAHIRA2.40 EGP (0.12/unit)
UVAMINE RETARD 100 MG 20 CAPS.MUP > ACINO47.00 EGP (2.35/unit)
MEPAFURAN 100 MG 20 CAPS.MEPACO54.00 EGP (2.70/unit)
MACROFURAN 100 MG 30 CAPS.KAHIRA82.00 EGP (2.73/unit)
3

AZITHROMYCIN

2nd line

Formoral.solid

Adult dose and duration

1 g as a single dose

Paediatric dose

10-12 mg/kg/dose [child max 500 mg]

(Infants, Children, and Adolescents: Oral: 10 to 12 mg/kg/dose once on day 1 (usual maximum dose: 500 mg/dose) followed by 5 to 6 mg/kg once daily (usual maximum dose: 250 mg/dose) for remainder of treatment duration.)

Dose by weight
3kg30-36 mg/dose
4kg40-48 mg/dose
5kg50-60 mg/dose
6kg60-72 mg/dose
7kg70-84 mg/dose
8kg80-96 mg/dose
9kg90-108 mg/dose
10kg100-120 mg/dose
11kg110-132 mg/dose
12kg120-144 mg/dose
13kg130-156 mg/dose
14kg140-168 mg/dose
15kg150-180 mg/dose
16kg160-192 mg/dose
17kg170-204 mg/dose
18kg180-216 mg/dose
19kg190-228 mg/dose
20kg200-240 mg/dose
21kg210-252 mg/dose
22kg220-264 mg/dose
23kg230-276 mg/dose
24kg240-288 mg/dose
25kg250-300 mg/dose
26kg260-312 mg/dose
27kg270-324 mg/dose
28kg280-336 mg/dose
29kg290-348 mg/dose
30kg300-360 mg/dose
31kg310-372 mg/dose
32kg320-384 mg/dose
33kg330-396 mg/dose
34kg340-408 mg/dose
35kg350-420 mg/dose
36kg360-432 mg/dose
37kg370-444 mg/dose
38kg380-456 mg/dose
39kg390-468 mg/dose
40kg400-480 mg/dose
41kg410-492 mg/dose
42kg420-500 mg/dose (upper capped)
43kg430-500 mg/dose (upper capped)
44kg440-500 mg/dose (upper capped)
45kg450-500 mg/dose (upper capped)
46kg460-500 mg/dose (upper capped)
47kg470-500 mg/dose (upper capped)
48kg480-500 mg/dose (upper capped)
49kg490-500 mg/dose (upper capped)
50kg500 mg/dose (capped)
AWaRe

WATCH group - carries resistance cost. Egyptian EML 2025.

Choice

Alternatives. The disease article gives single-dose azithromycin 1 g or doxycycline 100 mg twice daily for 7 days for urethritis; azithromycin stays the printed default as the incumbent and the single-dose option, with doxycycline as the 7-day alternative.

Dose source

Egyptian National Drug Formulary - Antimicrobial 2023

Why

Single-dose macrolide antibiotic coverage for nongonococcal urethritis causing male dysuria.

Cautions
  • Rising macrolide resistance - reserve for penicillin allergy.
  • The formulary's general paediatric regimen is 10-12 mg/kg on day 1 (max 500 mg) then 5-6 mg/kg once daily (max 250 mg). The flat five-day course here is the streptococcal-pharyngitis regimen and is deliberately different.
  • Reserve for penicillin allergy due to macrolide resistance.
  • QT prolongation can occur, so use caution with other QT-prolonging drugs.
Egyptian brands
Egyptian brandManufacturerIndicative price
AZATRIBACT 250MG 6 CAPS.RIVA PHARMA S.A.E.15.00 EGP (2.50/unit)
AZOMYCIN 250MG 6 CAPS.PHARCO25.20 EGP (4.20/unit)
AZATRIBACT 500MG 3 CAPS.RIVA PHARMA S.A.E.13.50 EGP (4.50/unit)
ZITHROMAX 250MG 6 CAPS.PFIZER79.00 EGP (13.17/unit)
ZITHROPRO 500 MG 6 F.C. TABS.EVA PHARMA103.00 EGP (17.17/unit)
AZROLID 500 MG 3 F.C.TABS.AMRIYA63.00 EGP (21.00/unit)
DISTABCIN 250 MG 6 DISPERSIBLE TABS.EGPI43.50 EGP
DISTABCIN 500 MG 3 DISPERSIBLE TABS.EGPI43.50 EGP
ZITHRODOSE 100MG/5ML SUSP. 15ML? strength differs? different route - not oral solidEL-OBOUR > AVERROES PHARMA-EGYPT12.00 EGP
ZITHROPHATE 200MG/5ML SUSP. 15ML? strength differs? different route - not oral solidORGANO PHARMA > NOVELL PHARMA12.75 EGP
4

DOXYCYCLINE

2nd line

Strength100 mg

Formoral.solid

Adult dose and duration

100 to 200 mg/day in 1 to 2 divided doses

Paediatric dose

2.2 mg/kg/dose [child max 100 mg]

(ENDF general paediatric dosing: 2.2 mg/kg/dose every 12 hours, maximum 100 mg/dose.)

Dose by weight
3kg6.6 mg/dose
4kg8.8 mg/dose
5kg11 mg/dose
6kg13.2 mg/dose
7kg15.4 mg/dose
8kg17.6 mg/dose
9kg19.8 mg/dose
10kg22 mg/dose
11kg24.2 mg/dose
12kg26.4 mg/dose
13kg28.6 mg/dose
14kg30.8 mg/dose
15kg33 mg/dose
16kg35.2 mg/dose
17kg37.4 mg/dose
18kg39.6 mg/dose
19kg41.8 mg/dose
20kg44 mg/dose
21kg46.2 mg/dose
22kg48.4 mg/dose
23kg50.6 mg/dose
24kg52.8 mg/dose
25kg55 mg/dose
26kg57.2 mg/dose
27kg59.4 mg/dose
28kg61.6 mg/dose
29kg63.8 mg/dose
30kg66 mg/dose
31kg68.2 mg/dose
32kg70.4 mg/dose
33kg72.6 mg/dose
34kg74.8 mg/dose
35kg77 mg/dose
36kg79.2 mg/dose
37kg81.4 mg/dose
38kg83.6 mg/dose
39kg85.8 mg/dose
40kg88 mg/dose
41kg90.2 mg/dose
42kg92.4 mg/dose
43kg94.6 mg/dose
44kg96.8 mg/dose
45kg99 mg/dose
46kg100 mg/dose (capped)
47kg100 mg/dose (capped)
48kg100 mg/dose (capped)
49kg100 mg/dose (capped)
50kg100 mg/dose (capped)
Dose source

Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph)

Why

Dysuria in men is commonly urethritis; the card carried azithromycin only, and the disease article names a tetracycline for the non-gonococcal cause.

Cautions
  • Hypersensitivity to doxycycline, other tetracyclines, or any component of the formulation
  • Use in children under 8 years should be reserved for severe, potentially life-threatening infections, or when better alternatives are unavailable.
  • The ENDF gives a general dosage range, not a urethritis-specific course - the indication and the need for partner treatment come from the disease article.
Egyptian brands
Egyptian brandManufacturerIndicative price
FARCODOXIN 100MG 10 CAPS.PHARCO11.00 EGP (1.10/unit)
DOXY M.R.100 MG 10 CAPS.ADWIA12.00 EGP (1.20/unit)
GRANUDOXY 100MG 10 F.C. TAB.GLOBAL NAPI PHARMACEUTICALS > PIERRE FRANCE12.00 EGP (1.20/unit)
DOXYDOX 100 MG 10 CAPS.EIPICO23.00 EGP (2.30/unit)
DOXYMYCIN 100 MG 10 CAPS.EL NILE.30.00 EGP (3.00/unit)
TABOCINE 100MG 10 CAPS.TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA46.00 EGP (4.60/unit)
VIBRAMYCIN 100MG 10 CAPS.PFIZER65.00 EGP (6.50/unit)
5

PHENAZOPYRIDINE

add-on - not a substitute

Strength100 mg

Formoral.solid

Adult dose and duration

200 mg (two 100 mg tablets) three times daily after meals x 2 days maximum when given alongside an antibiotic

Paediatric dose

Not used in young children in primary care. The label's dosing applies to adults and children 12 years and over.

Dose source

Phenazopyridine Hydrochloride 100 mg tablets, FDA label sections Indications and Usage and Dosage and Administration (DailyMed set id 860f30ef-cfe3-4c35-8baf-dd788f02ac94)

Why

A urinary mucosal analgesic that takes the edge off the burning in the first day or two while the antibiotic works. It treats nothing, and because it turns the urine bright orange it masks both the dipstick and visible blood - which is why the label caps it at two days.

Cautions
  • Do not give in G6PD deficiency without deliberate thought - it can cause haemolysis, and G6PD deficiency is common enough in Egypt for this to matter in practice.
  • Two days maximum alongside an antibiotic. The label states there is no evidence that longer adds anything.
  • Warn the patient the urine will turn reddish-orange, and that it stains clothing and permanently stains soft contact lenses.
  • A yellow tinge to the skin or the whites of the eyes means it is accumulating - stop it and check renal function.
  • Avoid in renal impairment.
  • It relieves the symptom and hides the signs. It is never a substitute for treating the infection, and never a reason to delay a culture.
Egyptian brands
Egyptian brandManufacturerIndicative price
URISEPT 100 MG 20 SUGAR C.TABS.KAHIRA5.00 EGP

GONOCOCCAL URETHRITIS - INJECTABLE

6

CEFTRIAXONE

Gonococcal urethritis - injectable

2nd line

Forminjection

Adult dose and duration

IV or IM: 1 to 2 g once daily, or divided twice daily

Paediatric dose

50-75 mg/kg/dose [child max 1000 mg]

(ENDF: mild to moderate infection, 50 to 75 mg/kg/dose once daily; maximum daily dose 1,000 mg/day.)

Dose by weight
3kg150-225 mg/dose
4kg200-300 mg/dose
5kg250-375 mg/dose
6kg300-450 mg/dose
7kg350-525 mg/dose
8kg400-600 mg/dose
9kg450-675 mg/dose
10kg500-750 mg/dose
11kg550-825 mg/dose
12kg600-900 mg/dose
13kg650-975 mg/dose
14kg700-1000 mg/dose (upper capped)
15kg750-1000 mg/dose (upper capped)
16kg800-1000 mg/dose (upper capped)
17kg850-1000 mg/dose (upper capped)
18kg900-1000 mg/dose (upper capped)
19kg950-1000 mg/dose (upper capped)
20kg1000 mg/dose (capped)
21kg1000 mg/dose (capped)
22kg1000 mg/dose (capped)
23kg1000 mg/dose (capped)
24kg1000 mg/dose (capped)
25kg1000 mg/dose (capped)
26kg1000 mg/dose (capped)
27kg1000 mg/dose (capped)
28kg1000 mg/dose (capped)
29kg1000 mg/dose (capped)
30kg1000 mg/dose (capped)
31kg1000 mg/dose (capped)
32kg1000 mg/dose (capped)
33kg1000 mg/dose (capped)
34kg1000 mg/dose (capped)
35kg1000 mg/dose (capped)
36kg1000 mg/dose (capped)
37kg1000 mg/dose (capped)
38kg1000 mg/dose (capped)
39kg1000 mg/dose (capped)
40kg1000 mg/dose (capped)
41kg1000 mg/dose (capped)
42kg1000 mg/dose (capped)
43kg1000 mg/dose (capped)
44kg1000 mg/dose (capped)
45kg1000 mg/dose (capped)
46kg1000 mg/dose (capped)
47kg1000 mg/dose (capped)
48kg1000 mg/dose (capped)
49kg1000 mg/dose (capped)
50kg1000 mg/dose (capped)
AWaRe

WATCH group - carries resistance cost. Egyptian EML 2025.

Dose source

Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph)

Why

The app's own assessment text names urethritis as the presumed cause of dysuria in men, but the card carried no agent active against N. gonorrhoeae - nitrofurantoin is a cystitis drug and azithromycin covers the chlamydial partner organism. The ENDF lists uncomplicated gonococcal infection (cervical/urethral, rectal, and pharyngeal) as a ceftriaxone indication.

Cautions
  • Hypersensitivity to ceftriaxone, any component of the formulation, or other cephalosporins
  • Do not use in hyperbilirubinaemic neonates, particularly those who are premature, since ceftriaxone is reported to displace bilirubin from albumin binding sites.
  • Do not give with intravenous calcium-containing solutions in neonates 28 days or younger.
  • The ENDF gives a general adult dose and lists uncomplicated gonococcal infection as an indication, but states no gonorrhoea-specific figure - the indication comes from the disease article, the dose from the monograph's general adult range.
  • Treat the sexual partner and test for co-infection; this is a disease-article instruction, not an ENDF dosing statement.
Egyptian brands
Egyptian brandManufacturerIndicative price
CEFAXONE 250MG I.V. VIAL.PHARCO B15.00 EGP
CEFOTRIX 250MG I.V.VIAL (U.S.P.23)UP PHARMA15.00 EGP
TRIXOMASH 500MG VIAL FOR I.V. INJ.RAMEDA > MASH PREMIERE16.50 EGP
TRIAXONE 500MG VIAL FOR I.M. INJ.TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA36.00 EGP
WINTRIAXONE 1 GM PD. FOR I.M INJ.SANOFI48.00 EGP
CEFTRIAXONE-SANDOZ 500 MG I.M. VIALPHARCO B > SANDOZ62.00 EGP
TRIAXONE 1 GM I.M. VIALTABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA106.00 EGP
TRIAXONE 1 GM I.V VIALTABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA106.00 EGP

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.